Strides Arcolab received a nod by the US FDA for an Oncology unit in Bengaluru. Arun Kumar, group CEO and vice chairman of Strides Arcolab, in an exclusive interview with CNBC-TV18 shares that the company expects approvals on approximately USD 4-5 billon product filings in the next few weeks.
first published: May 2, 2011 12:58 pm
A collection of the most-viewed Moneycontrol videos.
LIVE | US Navy seizes Iranian ship; talks uncertain; Nifty 200 DMA key, bank earnings focus now!
Iran Rejects US Talks Again, Strait Of Hormuz Tensions Rise As Oil Route Risks Grow
PM Modi Targets Congress After Women Reservation Bill Defeat, Vows To Remove Obstacles | FULL SPEECH
Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions
